Is UBIA or JNJ a better dividend investment in 2026?

UBIA currently yields 19801.98% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: UBIA offers higher current income.

What is the dividend yield difference between UBIA and JNJ?

UBIA has a forward dividend yield of 19801.98% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 19799.85 percentage points.

Home › Compare › UBIA vs JNJ

UBIA vs JNJ: Dividend Comparison 2026

UBIA yields 19801.98% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 UBIA wins by $47546058920768913408.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

UBIA

● Live price

19801.98%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47546058920768913408.00M

Annual income

$47,078,376,940,625,320,000,000,000.00

Full UBIA calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — UBIA vs JNJ

📍 UBIA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	UBIA	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, UBIA + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

UBIA pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBIA

Annual income on $10K today (after 15% tax)

$1,683,168.32/yr

After 10yr DRIP, annual income (after tax)

$40,016,620,399,531,510,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, UBIA beats the other by $40,016,620,399,531,510,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBIA + JNJ for your $10,000?

UBIA: 50%JNJ: 50%

100% JNJ50/50100% UBIA

Portfolio after 10yr

$23773029460384456704.00M

Annual income

$23,539,188,470,312,660,000,000,000.00/yr

Blended yield

99.02%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UBIA

No analyst data

Altman Z

-135.4

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBIA buys

JNJ buys

No recent congressional trades found for UBIA or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUBIAJNJ

Forward yield	19801.98% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$47546058920768913408.00M ✓	$30.3K
Annual income after 10y	$47,078,376,940,625,320,000,000,000.00 ✓	$4,689.40
Total dividends collected	$47515197738032734208.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: UBIA vs JNJ ($10,000, DRIP)

Year	UBIA Portfolio	UBIA Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,990,898	$1,980,198.02	$10,592	$272.30	+$1.98M → UBIA
2	$370,576,272	$368,446,010.88	$11,289	$357.73	+$370.56M → UBIA
3	$64,490,708,202	$64,094,191,591.53	$12,123	$472.89	+$64490.70M → UBIA
4	$10,493,485,886,438	$10,424,480,828,661.68	$13,141	$629.86	+$10493485.87M → UBIA
5	$1,596,461,721,077,093	$1,585,233,691,178,604.50	$14,408	$846.81	+$1596461721.06M → UBIA
6	$227,105,272,101,488,800	$225,397,058,059,936,320.00	$16,021	$1,151.60	+$227105272101.47M → UBIA
7	$30,209,306,017,893,183,000	$29,966,303,376,744,590,000.00	$18,122	$1,588.22	+$30209306017893.17M → UBIA
8	$3,757,638,318,856,096,700,000	$3,725,314,361,416,950,000,000.00	$20,930	$2,228.20	+$3757638318856096.50M → UBIA
9	$437,085,962,751,020,200,000,000	$433,065,289,749,844,160,000,000.00	$24,792	$3,191.91	+$437085962751020160.00M → UBIA
10	$47,546,058,920,768,910,000,000,000	$47,078,376,940,625,320,000,000,000.00	$30,274	$4,689.40	+$47546058920768913408.00M → UBIA

UBIA vs JNJ: Complete Analysis 2026

UBIA — Stock

UBI Blockchain Internet, Ltd. focuses on the research and application of blockchain technology with a focus on the Internet of things covering areas of food, drugs, and healthcare. It also operates an online store in China selling a range of products, including maternal and infant, cosmetics, wine, household goods, and digital and luxury products. The company was formerly known as JA Energy and changed its name to UBI Blockchain Internet, Ltd. in November 2016. UBI Blockchain Internet, Ltd. was founded in 2010 and is based in Hong Kong, Hong Kong.

Full UBIA Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this UBIA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBIA vs SCHD UBIA vs JEPI UBIA vs O UBIA vs KO UBIA vs MAIN UBIA vs ABBV UBIA vs MRK UBIA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.